
Elli Peselev
Examiner (ID: 18809)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1803, 1211, 1203, 1802, 1621, 1623, 2899 |
| Total Applications | 2819 |
| Issued Applications | 1829 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4295386
[patent_doc_number] => 06197757
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Particles, especially microparticles or nanoparticles, of crosslinked monosaccharides and oligosaccharides, processes for their preparation and cosmetic, pharmaceutical or food compositions in which they are present'
[patent_app_type] => 1
[patent_app_number] => 9/350131
[patent_app_country] => US
[patent_app_date] => 1999-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15740
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197757.pdf
[firstpage_image] =>[orig_patent_app_number] => 350131
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/350131 | Particles, especially microparticles or nanoparticles, of crosslinked monosaccharides and oligosaccharides, processes for their preparation and cosmetic, pharmaceutical or food compositions in which they are present | Jul 8, 1999 | Issued |
Array
(
[id] => 1602502
[patent_doc_number] => 06432681
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Compositions for treating Escherichia coli urinary tract infections'
[patent_app_type] => B1
[patent_app_number] => 09/350374
[patent_app_country] => US
[patent_app_date] => 1999-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 9189
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/432/06432681.pdf
[firstpage_image] =>[orig_patent_app_number] => 09350374
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/350374 | Compositions for treating Escherichia coli urinary tract infections | Jul 8, 1999 | Issued |
Array
(
[id] => 4408657
[patent_doc_number] => 06239112
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-29
[patent_title] => 'Water miscible macrolide solutions'
[patent_app_type] => 1
[patent_app_number] => 9/346905
[patent_app_country] => US
[patent_app_date] => 1999-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3689
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/239/06239112.pdf
[firstpage_image] =>[orig_patent_app_number] => 346905
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/346905 | Water miscible macrolide solutions | Jul 1, 1999 | Issued |
Array
(
[id] => 4408666
[patent_doc_number] => 06239113
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-29
[patent_title] => 'Topical treatment or prevention of ocular infections'
[patent_app_type] => 1
[patent_app_number] => 9/346923
[patent_app_country] => US
[patent_app_date] => 1999-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7764
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/239/06239113.pdf
[firstpage_image] =>[orig_patent_app_number] => 346923
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/346923 | Topical treatment or prevention of ocular infections | Jul 1, 1999 | Issued |
Array
(
[id] => 4238852
[patent_doc_number] => 06090788
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-18
[patent_title] => 'Phototherapy based method for treating pathogens and composition for effecting same'
[patent_app_type] => 1
[patent_app_number] => 9/343199
[patent_app_country] => US
[patent_app_date] => 1999-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8588
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/090/06090788.pdf
[firstpage_image] =>[orig_patent_app_number] => 343199
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/343199 | Phototherapy based method for treating pathogens and composition for effecting same | Jun 29, 1999 | Issued |
Array
(
[id] => 4073631
[patent_doc_number] => 06069238
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-30
[patent_title] => 'Spirocyclic C-glycosides'
[patent_app_type] => 1
[patent_app_number] => 9/342073
[patent_app_country] => US
[patent_app_date] => 1999-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7080
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/069/06069238.pdf
[firstpage_image] =>[orig_patent_app_number] => 342073
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/342073 | Spirocyclic C-glycosides | Jun 27, 1999 | Issued |
Array
(
[id] => 4311474
[patent_doc_number] => 06316403
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Methods for treating an ischemic disorder and improving stroke outcome'
[patent_app_type] => 1
[patent_app_number] => 9/269426
[patent_app_country] => US
[patent_app_date] => 1999-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 103
[patent_no_of_words] => 52006
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316403.pdf
[firstpage_image] =>[orig_patent_app_number] => 269426
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/269426 | Methods for treating an ischemic disorder and improving stroke outcome | Jun 24, 1999 | Issued |
Array
(
[id] => 4304055
[patent_doc_number] => 06251876
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies'
[patent_app_type] => 1
[patent_app_number] => 9/202817
[patent_app_country] => US
[patent_app_date] => 1999-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 11299
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/251/06251876.pdf
[firstpage_image] =>[orig_patent_app_number] => 202817
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/202817 | Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies | Jun 24, 1999 | Issued |
Array
(
[id] => 4237254
[patent_doc_number] => 06165985
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => '11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them'
[patent_app_type] => 1
[patent_app_number] => 9/338602
[patent_app_country] => US
[patent_app_date] => 1999-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4361
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/165/06165985.pdf
[firstpage_image] =>[orig_patent_app_number] => 338602
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/338602 | 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them | Jun 22, 1999 | Issued |
Array
(
[id] => 4234490
[patent_doc_number] => 06117845
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-12
[patent_title] => 'C-linked analogs of N-(4-hydroxyphenyl) retinamide'
[patent_app_type] => 1
[patent_app_number] => 9/330628
[patent_app_country] => US
[patent_app_date] => 1999-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5228
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/117/06117845.pdf
[firstpage_image] =>[orig_patent_app_number] => 330628
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/330628 | C-linked analogs of N-(4-hydroxyphenyl) retinamide | Jun 10, 1999 | Issued |
Array
(
[id] => 1436140
[patent_doc_number] => 06355784
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-12
[patent_title] => 'Methods and compositions for the manufacture of halogenated anthracyclines with increased antitumor activity, other anthracyclines, halogenated sugars, and glycosyl donors'
[patent_app_type] => B1
[patent_app_number] => 09/330226
[patent_app_country] => US
[patent_app_date] => 1999-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 19
[patent_no_of_words] => 19949
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/355/06355784.pdf
[firstpage_image] =>[orig_patent_app_number] => 09330226
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/330226 | Methods and compositions for the manufacture of halogenated anthracyclines with increased antitumor activity, other anthracyclines, halogenated sugars, and glycosyl donors | Jun 9, 1999 | Issued |
Array
(
[id] => 4418924
[patent_doc_number] => 06177265
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-23
[patent_title] => 'Process for the manufacture of a starch hydrolysate with high content'
[patent_app_type] => 1
[patent_app_number] => 9/328951
[patent_app_country] => US
[patent_app_date] => 1999-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3806
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/177/06177265.pdf
[firstpage_image] =>[orig_patent_app_number] => 328951
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/328951 | Process for the manufacture of a starch hydrolysate with high content | Jun 8, 1999 | Issued |
Array
(
[id] => 4295852
[patent_doc_number] => 06184213
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'Diluent and disintegrating composition, its method of achievement and its use'
[patent_app_type] => 1
[patent_app_number] => 9/328064
[patent_app_country] => US
[patent_app_date] => 1999-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 7
[patent_no_of_words] => 4437
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/184/06184213.pdf
[firstpage_image] =>[orig_patent_app_number] => 328064
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/328064 | Diluent and disintegrating composition, its method of achievement and its use | Jun 7, 1999 | Issued |
| 09/327784 | 6-0-CARBAMATE KETOLIDE DERIVATIVES | Jun 6, 1999 | Abandoned |
Array
(
[id] => 4102800
[patent_doc_number] => 06066727
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-23
[patent_title] => 'Organopolysiloxane-grafted polysaccharide compound'
[patent_app_type] => 1
[patent_app_number] => 9/325797
[patent_app_country] => US
[patent_app_date] => 1999-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2850
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/066/06066727.pdf
[firstpage_image] =>[orig_patent_app_number] => 325797
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/325797 | Organopolysiloxane-grafted polysaccharide compound | Jun 3, 1999 | Issued |
Array
(
[id] => 4295614
[patent_doc_number] => 06184196
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'Sucrose based surfactants and methods thereof'
[patent_app_type] => 1
[patent_app_number] => 9/321225
[patent_app_country] => US
[patent_app_date] => 1999-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 13869
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/184/06184196.pdf
[firstpage_image] =>[orig_patent_app_number] => 321225
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/321225 | Sucrose based surfactants and methods thereof | May 26, 1999 | Issued |
Array
(
[id] => 4192720
[patent_doc_number] => 06043227
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-28
[patent_title] => 'C11 carbamates of macrolide antibacterials'
[patent_app_type] => 1
[patent_app_number] => 9/320352
[patent_app_country] => US
[patent_app_date] => 1999-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10546
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/043/06043227.pdf
[firstpage_image] =>[orig_patent_app_number] => 320352
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/320352 | C11 carbamates of macrolide antibacterials | May 25, 1999 | Issued |
Array
(
[id] => 4290381
[patent_doc_number] => 06268488
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Prodrug activation using catalytic antibodies'
[patent_app_type] => 1
[patent_app_number] => 9/318661
[patent_app_country] => US
[patent_app_date] => 1999-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11181
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268488.pdf
[firstpage_image] =>[orig_patent_app_number] => 318661
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/318661 | Prodrug activation using catalytic antibodies | May 24, 1999 | Issued |
Array
(
[id] => 1435977
[patent_doc_number] => 06355620
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-12
[patent_title] => 'C-2 modified erythromycin derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/312517
[patent_app_country] => US
[patent_app_date] => 1999-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20584
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 754
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/355/06355620.pdf
[firstpage_image] =>[orig_patent_app_number] => 09312517
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/312517 | C-2 modified erythromycin derivatives | May 13, 1999 | Issued |
Array
(
[id] => 4176816
[patent_doc_number] => 06084081
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-04
[patent_title] => 'Lewis X derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/254670
[patent_app_country] => US
[patent_app_date] => 1999-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19046
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/084/06084081.pdf
[firstpage_image] =>[orig_patent_app_number] => 254670
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254670 | Lewis X derivatives | May 5, 1999 | Issued |